Molecure S.A. (WSE:MOC)
6.27
-0.17 (-2.64%)
Sep 4, 2026, 5:01 PM CET
Molecure Market Cap
Molecure has a market cap or net worth of 129.18 million as of September 4, 2026. Its market cap has decreased by -15.42% in one year.
Market Cap
129.18M
Enterprise Value
112.30M
Revenue
6.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.27
ChartMarket Cap Chart
Since April 19, 2018, Molecure's market cap has decreased from 338.43M to 129.18M, a decrease of -61.83%. That is a compound annual growth rate of -10.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 129.18M | -5.00% |
| Dec 30, 2025 | 135.98M | -20.03% |
| Dec 30, 2024 | 170.04M | -48.21% |
| Dec 29, 2023 | 328.30M | 64.10% |
| Dec 30, 2022 | 200.07M | -61.66% |
| Dec 30, 2021 | 521.79M | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 512.23M |
| Captor Therapeutics Spolka Akcyjna | 451.09M |
| Bioceltix | 438.15M |
| Ryvu Therapeutics | 401.83M |
| BIOTON | 321.13M |
| Synthaverse | 229.21M |
| Poltreg | 134.30M |
| Mabion | 124.29M |